Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-04-01 Sale | 2026-04-06 5:48 pm | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 30,078 | $24.58 | $739,317 | 1,150,205 (Indirect Direct) | View |
| 2026-04-01 Sale | 2026-04-06 5:44 pm | Beam Therapeutics Inc. | BEAM | Simon Amy Chief Medical Officer | 6,700 | $24.58 | $164,686 | 102,735 (Direct) | View |
| 2026-04-01 Sale | 2026-04-06 5:39 pm | Beam Therapeutics Inc. | BEAM | Cavanagh Bethany J SVP, Finance and Treasurer | 3,242 | $24.58 | $79,688 | 51,171 (Direct) | View |
| 2026-04-01 Sale | 2026-04-06 5:39 pm | Beam Therapeutics Inc. | BEAM | Bellon Christine Chief Legal Officer | 5,956 | $24.58 | $146,398 | 109,711 (Direct) | View |
| 2026-04-01 Sale | 2026-04-06 5:34 pm | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President | 11,810 | $24.58 | $290,290 | 218,406 (Direct) | View |
| 2026-03-30 Sale | 2026-04-01 6:32 pm | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 50,000 | $22.57 | $1,128,315 | 1,242,011 (Indirect Direct) | View |
| 2026-02-24 Sale | 2026-02-26 4:05 pm | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President | 35,000 | $32 | $1,120,042 | 587,529 (Direct) | View |
| 2026-01-29 Sale | 2026-02-02 4:05 pm | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 50,000 | $28.87 | $1,443,528 | 1,432,011 (Indirect Direct) | View |
| 2026-01-22 Sale | 2026-01-26 4:05 pm | Beam Therapeutics Inc. | BEAM | Cavanagh Bethany J SVP, Finance and Treasurer | 6,198 | $35 | $216,933 | 34,813 (Direct) | View |
| 2026-01-22 Sale | 2026-01-26 4:05 pm | Beam Therapeutics Inc. | BEAM | Bellon Christine Chief Legal Officer | 1,371 | $34 | $46,614 | 95,667 (Direct) | View |
| 2026-01-20 Sale | 2026-01-21 4:05 pm | Beam Therapeutics Inc. | BEAM | Cavanagh Bethany J SVP, Finance and Treasurer | 3,034 | $30.12 | $91,384 | 41,011 (Direct) | View |
| 2026-01-15 Sale | 2026-01-20 4:05 pm | Beam Therapeutics Inc. | BEAM | Bellon Christine Chief Legal Officer | 18,629 | $34.61 | $644,832 | 97,038 (Direct) | View |
| 2025-12-31 Sale | 2026-01-05 4:16 pm | Beam Therapeutics Inc. | BEAM | Emany Sravan Kumar Chief Financial Officer | 6,294 | $27.1 | $170,567 | 73,706 (Direct) | View |
| 2025-12-31 Sale | 2026-01-05 4:12 pm | Beam Therapeutics Inc. | BEAM | Bellon Christine Chief Legal Officer | 1,254 | $27.1 | $33,983 | 115,667 (Direct) | View |
| 2025-10-27 Sale | 2025-10-29 1:13 pm | Beam Therapeutics Inc. | BEAM | FMR LLC See Remark 1 10% Owner | 459 | $26.68 | $12,246 | 1,980,688 (Indirect) | View |
| 2025-10-01 Sale | 2025-10-03 4:15 pm | Beam Therapeutics Inc. | BEAM | Cavanagh Bethany J SVP, Finance and Treasurer | 467 | $24.53 | $11,456 | 44,045 (Direct) | View |
| 2025-10-01 Sale | 2025-10-03 4:10 pm | Beam Therapeutics Inc. | BEAM | Bellon Christine Chief Legal Officer | 373 | $24.53 | $9,150 | 116,921 (Direct) | View |
| 2025-10-01 Sale | 2025-10-03 4:05 pm | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 50,000 | $24.57 | $1,228,323 | 1,153,339 (Indirect Direct) | View |
| 2025-07-30 Sale | 2025-08-01 09:36 am | Beam Therapeutics Inc. | BEAM | FMR LLC See Remark 1 10% Owner | 48,374 | $20.5 | $991,667 | 3,213,581 (Indirect) | View |
| 2025-07-01 Sale | 2025-07-03 5:30 pm | Beam Therapeutics Inc. | BEAM | Simon Amy Chief Medical Officer | 1,250 | $19.17 | $23,962 | 64,864 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-03-31 Option Award | 2026-04-02 5:27 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Bellon Christine Chief Legal Officer | 20,000 | $0 | 115,667 (Direct) | View |
| 2026-03-31 Option Award | 2026-04-02 5:22 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Cavanagh Bethany J SVP, Finance and Treasurer | 20,000 | $0 | 54,813 (Direct) | View |
| 2026-03-31 Option Award | 2026-04-02 5:16 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Simon Amy Chief Medical Officer | 31,750 | $0 | 109,114 (Direct) | View |
| 2026-03-31 Option Award | 2026-04-02 5:16 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Emany Sravan Kumar Chief Financial Officer | 31,750 | $0 | 105,456 (Direct) | View |
| 2026-03-31 Option Award | 2026-04-02 5:15 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President | 40,000 | $0 | 230,216 (Direct) | View |
| 2026-03-30 Exercise | 2026-04-01 6:32 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 50,000 | $0.67 | 1,242,011 (Direct) | View |
| 2026-03-31 Option Award | 2026-04-01 6:32 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 90,000 | $0 | 1,242,011 (Direct) | View |
| 2026-03-30 Exercise | 2026-04-01 6:32 pm | N/A 2028-05-08 | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 50,000 | $0 | 1,242,011 (Direct) | View |
| 2026-02-24 Exercise | 2026-02-26 4:05 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President | 35,000 | $17 | 587,529 (Direct) | View |
| 2026-02-24 Exercise | 2026-02-26 4:05 pm | N/A 2030-02-05 | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President | 35,000 | $0 | 587,529 (Direct) | View |
| 2026-01-31 Option Award | 2026-02-02 4:05 pm | N/A 2036-01-31 | Beam Therapeutics Inc. | BEAM | Cavanagh Bethany J SVP, Finance and Treasurer | 40,000 | $0 | 40,000 (Direct) | View |
| 2026-01-31 Option Award | 2026-02-02 4:05 pm | N/A 2036-01-31 | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President | 80,000 | $0 | 80,000 (Direct) | View |
| 2026-01-31 Option Award | 2026-02-02 4:05 pm | N/A 2036-01-31 | Beam Therapeutics Inc. | BEAM | Emany Sravan Kumar Chief Financial Officer | 63,500 | $0 | 63,500 (Direct) | View |
| 2026-01-31 Option Award | 2026-02-02 4:05 pm | N/A 2036-01-31 | Beam Therapeutics Inc. | BEAM | Bellon Christine Chief Legal Officer | 40,000 | $0 | 40,000 (Direct) | View |
| 2026-01-29 Exercise | 2026-02-02 4:05 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 50,000 | $0.67 | 1,432,011 (Direct) | View |
| 2026-01-31 Option Award | 2026-02-02 4:05 pm | N/A 2036-01-31 | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 180,000 | $0 | 1,432,011 (Direct) | View |
| 2026-01-29 Exercise | 2026-02-02 4:05 pm | N/A 2028-05-08 | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 50,000 | $0 | 1,432,011 (Direct) | View |
| 2026-01-31 Option Award | 2026-02-02 4:05 pm | N/A 2036-01-31 | Beam Therapeutics Inc. | BEAM | Simon Amy Chief Medical Officer | 88,500 | $0 | 88,500 (Direct) | View |
| 2025-12-31 Option Award | 2026-01-05 4:11 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Simon Amy Chief Medical Officer | 12,500 | $0 | 77,364 (Direct) | View |
| 2025-10-06 Gift | 2025-10-08 3:37 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | FMR LLC See Remark 1 10% Owner | 1,232,434 | $0 | 1,981,147 (Indirect) | View |
| 2025-10-01 Exercise | 2025-10-03 4:05 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 50,000 | $0.67 | 1,153,339 (Direct) | View |
| 2025-10-01 Exercise | 2025-10-03 4:05 pm | N/A 2028-05-08 | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 50,000 | $0 | 1,153,339 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:05 pm | N/A 2035-06-04 | Beam Therapeutics Inc. | BEAM | Walsh Kathleen E Director | 33,662 | $0 | 33,662 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:05 pm | N/A 2035-06-04 | Beam Therapeutics Inc. | BEAM | Fishman Mark Director | 33,662 | $0 | 33,662 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:05 pm | N/A 2025-06-04 | Beam Therapeutics Inc. | BEAM | Shaw Christi Director | 33,662 | $0 | 33,662 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:05 pm | N/A 2035-06-04 | Beam Therapeutics Inc. | BEAM | Ho Carole Director | 33,662 | $0 | 33,662 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:05 pm | N/A 2035-06-04 | Beam Therapeutics Inc. | BEAM | MARAGANORE JOHN Director | 33,662 | $0 | 33,662 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:05 pm | N/A 2035-06-04 | Beam Therapeutics Inc. | BEAM | COOPER GRAHAM K Director | 33,662 | $0 | 33,662 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:05 pm | N/A 2025-06-04 | Beam Therapeutics Inc. | BEAM | Guindo Chirfi Director | 33,662 | $0 | 33,662 (Direct) | View |
Ownership | 2025-04-10 09:36 am | N/A N/A | Beam Therapeutics Inc. | BEAM | FMR LLC See Remark 1 10% Owner | 0 | $0 | 3,261,955 (Indirect) | View |